Tracking bluefin tuna cohorts from east Atlantic Spanish fisheries since the 1980s

Relative abundance and mean size at age analyses were performed for the catches of three Atlantic Spanish fisheries, in search of an exceptionally abundant cohort in the recent history of the eastern Atlantic and Mediterranean bluefin tuna stock. Length distributions of baitboat fisheries, both in the Bay of Biscay and areas close to the Strait of Gibraltar as well as trap catches from the Spanish Atlantic coast were converted to age distributions using age length keys from calcified structures. Results do validate indirectly the ageing method. The 1994 cohort was clearly tracked for juveniles and young adults, 3 to 7 years old, in baitboat catches, and also for older specimens, 9 to 11 years old, in the trap fisheries. Based on these results, it is suggested that the juvenile and young adults fisheries in the western part of the Iberian Peninsula are interconnected between one another and with the Balearic Islands area of the western Mediterranean, as it is the nearest spawning ground described and because it is also supported by tagging and other studies.Afin de trouver une cohorte exceptionnellement abondante dans la récente histoire du stock de ton rouge de l’Atlantique Est et de la Méditerranée, on a procédé à une analyse de l’abondance relative et de la taille moyenne par âge des captures réalisées par trois pêcheries espagnoles de l’Atlantique. Les distributions par tailles de deux pêcheries de canneurs dans le Golfe de Gascogne et dans les eaux proches du Détroit de Gibraltar, ainsi que les prises des madragues de la côte atlantique espagnole, ont été converties en âges à l’aide des clefs taille-âge obtenues à partir de la lecture de structures calcifiées. Les résultats valident indirectement la méthode de détermination de l’âge. La cohorte de 1994 affiche une forte indication présente chez les juvéniles et les jeunes adultes, de 3 à 7 ans, capturés dans les pêcheries de canneurs ainsi que chez les spécimens d’âge plus avancé, de 9 à 11 ans, pêchés à la madrague. Ces résultats suggèrent que les pêcheries de juvéniles et de jeunes adultes de la partie occidentale de la péninsule ibérique sont interconnectées entre elles ainsi qu’avec la zone des îles Baléares, en Méditerranée occidentale, étant donné qu’il s’agit de la zone de frai la plus proche et qu’il existe des indices de cette relation d’après les études de marquage et d’autres études.Para encontrar una cohorte excepcionalmente abundante en la historia reciente del stock de atún rojo del Atlántico este y Mediterráneo, se realizó un análisis de la abundancia relativa y la talla media por edad de las capturas de tres pesquerías atlánticas españolas. Las distribuciones de tallas de dos pesquerías de cebo vivo, en el Golfo de Vizcaya y en aguas próximas al Estrecho de Gibraltar, así como las capturas de las almadrabas de la costa atlántica española, fueron convertidas a edades mediante el uso de claves talla edad, obtenidas a partir de la lectura de piezas esqueléticas. Los resultados validan indirectamente el método de determinación de la edad. La cohorte de 1994 presenta una fuerte señal que pudo ser encontrada en los juveniles y adultos jóvenes, 3 a 7 años, capturados en las pesquerías de cebo vivo y también en especimenes mayores, 9 a 11 años, pescados con las almadrabas. Con esto resultados se sugiere que las pesquerías de juveniles y adultos jóvenes de la parte occidental de la península Ibérica están interconectadas entre ellas y con el área de las Islas Baleares, en el Mediterráneo occidental, puesto que es la zona de puesta más próxima y porque también hay evidencias de esta relación mediante el marcado y otros estudios

Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

Objectives: The objective of this study was to estimate the association between tocilizumab or corticosteroids and the risk of intubation or death in patients with coronavirus disease 19 (COVID-19) with a hyperinflammatory state according to clinical and laboratory parameters. Methods: A cohort study was performed in 60 Spanish hospitals including 778 patients with COVID-19 and clinical and laboratory data indicative of a hyperinflammatory state. Treatment was mainly with tocilizumab, an intermediate-high dose of corticosteroids (IHDC), a pulse dose of corticosteroids (PDC), combination therapy, or no treatment. Primary outcome was intubation or death; follow-up was 21 days. Propensity score-adjusted estimations using Cox regression (logistic regression if needed) were calculated. Propensity scores were used as confounders, matching variables and for the inverse probability of treatment weights (IPTWs). Results: In all, 88, 117, 78 and 151 patients treated with tocilizumab, IHDC, PDC, and combination therapy, respectively, were compared with 344 untreated patients. The primary endpoint occurred in 10 (11.4%), 27 (23.1%), 12 (15.4%), 40 (25.6%) and 69 (21.1%), respectively. The IPTW-based hazard ratios (odds ratio for combination therapy) for the primary endpoint were 0.32 (95%CI 0.22-0.47; p < 0.001) for tocilizumab, 0.82 (0.71-1.30; p 0.82) for IHDC, 0.61 (0.43-0.86; p 0.006) for PDC, and 1.17 (0.86-1.58; p 0.30) for combination therapy. Other applications of the propensity score provided similar results, but were not significant for PDC. Tocilizumab was also associated with lower hazard of death alone in IPTW analysis (0.07; 0.02-0.17; p < 0.001). Conclusions: Tocilizumab might be useful in COVID-19 patients with a hyperinflammatory state and should be prioritized for randomized trials in this situatio

Fracturas patológicas como forma de presentación de un mieloma múltiple no secretor: un dilema diagnóstico

We present the clinical case of a 60 year-old woman who was admitted to our hospital referring a precordial pleuromechanic pain and was diagnosed with multiple bone fractures. A bone marrow biopsy gave the diagnosis of multiple myeloma and no monoclonal peak was detected, neither light chains in blood nor urine. The final diagnosis was non-secretory multiple myeloma and secondary spontaneous fractures. Non-secretory multiple myeloma represents only 3% of all multiple myelomas and has several characteristics that make it important to distinguish from other myelomas.Presentamos el caso de una mujer de 60 años de edad que acudió a nuestro hospital por dolor precordial pleuromecánico y fue diagnosticada de fracturas óseas multiples. La biopsia de médula ósea dio el diagnóstico de mieloma multiple y no se detectó pico monoclonal, ni tampoco cadenas ligeras en sangre ni orina. El diagnóstico final fue de mieloma múltiple no secretor y fracturas espontáneas secundarias. El mieloma múltiple no secretor representa solo el 3% del total de mielomas múltiples y tiene características peculiares que hacen necesaria su distinction del resto de mielomas

Tracking bluefin tuna cohorts from east Atlantic Spanish fisheries since the 1980s

Relative abundance and mean size at age analyses were performed for the catches of three Atlantic Spanish fisheries, in search of an exceptionally abundant cohort in the recent history of the eastern Atlantic and Mediterranean bluefin tuna stock. Length distributions of baitboat fisheries, both in the Bay of Biscay and areas close to the Strait of Gibraltar as well as trap catches from the Spanish Atlantic coast were converted to age distributions using age length keys from calcified structures. Results do validate indirectly the ageing method. The 1994 cohort was clearly tracked for juveniles and young adults, 3 to 7 years old, in baitboat catches, and also for older specimens, 9 to 11 years old, in the trap fisheries. Based on these results, it is suggested that the juvenile and young adults fisheries in the western part of the Iberian Peninsula are interconnected between one another and with the Balearic Islands area of the western Mediterranean, as it is the nearest spawning ground described and because it is also supported by tagging and other studies.Afin de trouver une cohorte exceptionnellement abondante dans la récente histoire du stock de ton rouge de l’Atlantique Est et de la Méditerranée, on a procédé à une analyse de l’abondance relative et de la taille moyenne par âge des captures réalisées par trois pêcheries espagnoles de l’Atlantique. Les distributions par tailles de deux pêcheries de canneurs dans le Golfe de Gascogne et dans les eaux proches du Détroit de Gibraltar, ainsi que les prises des madragues de la côte atlantique espagnole, ont été converties en âges à l’aide des clefs taille-âge obtenues à partir de la lecture de structures calcifiées. Les résultats valident indirectement la méthode de détermination de l’âge. La cohorte de 1994 affiche une forte indication présente chez les juvéniles et les jeunes adultes, de 3 à 7 ans, capturés dans les pêcheries de canneurs ainsi que chez les spécimens d’âge plus avancé, de 9 à 11 ans, pêchés à la madrague. Ces résultats suggèrent que les pêcheries de juvéniles et de jeunes adultes de la partie occidentale de la péninsule ibérique sont interconnectées entre elles ainsi qu’avec la zone des îles Baléares, en Méditerranée occidentale, étant donné qu’il s’agit de la zone de frai la plus proche et qu’il existe des indices de cette relation d’après les études de marquage et d’autres études.Para encontrar una cohorte excepcionalmente abundante en la historia reciente del stock de atún rojo del Atlántico este y Mediterráneo, se realizó un análisis de la abundancia relativa y la talla media por edad de las capturas de tres pesquerías atlánticas españolas. Las distribuciones de tallas de dos pesquerías de cebo vivo, en el Golfo de Vizcaya y en aguas próximas al Estrecho de Gibraltar, así como las capturas de las almadrabas de la costa atlántica española, fueron convertidas a edades mediante el uso de claves talla edad, obtenidas a partir de la lectura de piezas esqueléticas. Los resultados validan indirectamente el método de determinación de la edad. La cohorte de 1994 presenta una fuerte señal que pudo ser encontrada en los juveniles y adultos jóvenes, 3 a 7 años, capturados en las pesquerías de cebo vivo y también en especimenes mayores, 9 a 11 años, pescados con las almadrabas. Con esto resultados se sugiere que las pesquerías de juveniles y adultos jóvenes de la parte occidental de la península Ibérica están interconectadas entre ellas y con el área de las Islas Baleares, en el Mediterráneo occidental, puesto que es la zona de puesta más próxima y porque también hay evidencias de esta relación mediante el marcado y otros estudios

COVID-19 in hospitalized HIV-positive and HIV-negative patients : A matched study

CatedresObjectives: We compared the characteristics and clinical outcomes of hospitalized individuals with COVID-19 with [people with HIV (PWH)] and without (non-PWH) HIV co-infection in Spain during the first wave of the pandemic. Methods: This was a retrospective matched cohort study. People with HIV were identified by reviewing clinical records and laboratory registries of 10 922 patients in active-follow-up within the Spanish HIV Research Network (CoRIS) up to 30 June 2020. Each hospitalized PWH was matched with five non-PWH of the same age and sex randomly selected from COVID-19@Spain, a multicentre cohort of 4035 patients hospitalized with confirmed COVID-19. The main outcome was all-cause in-hospital mortality. Results: Forty-five PWH with PCR-confirmed COVID-19 were identified in CoRIS, 21 of whom were hospitalized. A total of 105 age/sex-matched controls were selected from the COVID-19@Spain cohort. The median age in both groups was 53 (Q1-Q3, 46-56) years, and 90.5% were men. In PWH, 19.1% were injecting drug users, 95.2% were on antiretroviral therapy, 94.4% had HIV-RNA < 50 copies/mL, and the median (Q1-Q3) CD4 count was 595 (349-798) cells/μL. No statistically significant differences were found between PWH and non-PWH in number of comorbidities, presenting signs and symptoms, laboratory parameters, radiology findings and severity scores on admission. Corticosteroids were administered to 33.3% and 27.4% of PWH and non-PWH, respectively (P = 0.580). Deaths during admission were documented in two (9.5%) PWH and 12 (11.4%) non-PWH (P = 0.800). Conclusions: Our findings suggest that well-controlled HIV infection does not modify the clinical presentation or worsen clinical outcomes of COVID-19 hospitalization

Discovering HIV related information by means of association rules and machine learning

Acquired immunodeficiency syndrome (AIDS) is still one of the main health problems worldwide. It is therefore essential to keep making progress in improving the prognosis and quality of life of affected patients. One way to advance along this pathway is to uncover connections between other disorders associated with HIV/AIDS-so that they can be anticipated and possibly mitigated. We propose to achieve this by using Association Rules (ARs). They allow us to represent the dependencies between a number of diseases and other specific diseases. However, classical techniques systematically generate every AR meeting some minimal conditions on data frequency, hence generating a vast amount of uninteresting ARs, which need to be filtered out. The lack of manually annotated ARs has favored unsupervised filtering, even though they produce limited results. In this paper, we propose a semi-supervised system, able to identify relevant ARs among HIV-related diseases with a minimal amount of annotated training data. Our system has been able to extract a good number of relationships between HIV-related diseases that have been previously detected in the literature but are scattered and are often little known. Furthermore, a number of plausible new relationships have shown up which deserve further investigation by qualified medical experts

How do women living with HIV experience menopause? Menopausal symptoms, anxiety and depression according to reproductive age in a multicenter cohort

CatedresBackground: To estimate the prevalence and severity of menopausal symptoms and anxiety/depression and to assess the differences according to menopausal status among women living with HIV aged 45-60 years from the cohort of Spanish HIV/AIDS Research Network (CoRIS). Methods: Women were interviewed by phone between September 2017 and December 2018 to determine whether they had experienced menopausal symptoms and anxiety/depression. The Menopause Rating Scale was used to evaluate the prevalence and severity of symptoms related to menopause in three subscales: somatic, psychologic and urogenital; and the 4-item Patient Health Questionnaire was used for anxiety/depression. Logistic regression models were used to estimate odds ratios (ORs) of association between menopausal status, and other potential risk factors, the presence and severity of somatic, psychological and urogenital symptoms and of anxiety/depression. Results: Of 251 women included, 137 (54.6%) were post-, 70 (27.9%) peri- and 44 (17.5%) pre-menopausal, respectively. Median age of onset menopause was 48 years (IQR 45-50). The proportions of pre-, peri- and post-menopausal women who had experienced any menopausal symptoms were 45.5%, 60.0% and 66.4%, respectively. Both peri- and post-menopause were associated with a higher likelihood of having somatic symptoms (aOR 3.01; 95% CI 1.38-6.55 and 2.63; 1.44-4.81, respectively), while post-menopause increased the likelihood of having psychological (2.16; 1.13-4.14) and urogenital symptoms (2.54; 1.42-4.85). By other hand, post-menopausal women had a statistically significant five-fold increase in the likelihood of presenting severe urogenital symptoms than pre-menopausal women (4.90; 1.74-13.84). No significant differences by menopausal status were found for anxiety/depression. Joint/muscle problems, exhaustion and sleeping disorders were the most commonly reported symptoms among all women. Differences in the prevalences of vaginal dryness (p = 0.002), joint/muscle complaints (p = 0.032), and sweating/flush (p = 0.032) were found among the three groups. Conclusions: Women living with HIV experienced a wide variety of menopausal symptoms, some of them initiated before women had any menstrual irregularity. We found a higher likelihood of somatic symptoms in peri- and post-menopausal women, while a higher likelihood of psychological and urogenital symptoms was found in post-menopausal women. Most somatic symptoms were of low or moderate severity, probably due to the good clinical and immunological situation of these women

Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice : A multicentre cohort study

Background: The aim of this study was to investigate the effectiveness and tolerability of the combination elvitegravir/cobicistat/tenofovir/emtricitabine plus darunavir (EVG/COB/TFV/FTC + DRV) in treatment-experienced patients from the cohort of the Spanish HIV/AIDS Research Network (CoRIS). Methods: Treatment-experienced patients starting treatment with EVG/COB/TFV/FTC + DRV during the years 2014-2018 and with more than 24 weeks of follow-up were included. TFV could be administered either as tenofovir disoproxil fumarate or tenofovir alafenamide. We evaluated virological response, defined as viral load (VL) < 50 copies/ml and < 200 copies/ml at 24 and 48 weeks after starting this regimen, stratified by baseline VL (< 50 or ≥ 50 copies/ml at the start of the regimen). Results: We included 39 patients (12.8% women). At baseline, 10 (25.6%) patients had VL < 50 copies/ml and 29 (74.4%) had ≥ 50 copies/ml. Among patients with baseline VL < 50 copies/ml, 85.7% and 80.0% had VL < 50 copies/ml at 24 and 48 weeks, respectively, and 100% had VL < 200 copies/ml at 24 and 48 weeks. Among patients with baseline VL ≥ 50 copies/ml, 42.3% and 40.9% had VL < 50 copies/ml and 69.2% and 68.2% had VL < 200 copies/ml at 24 and 48 weeks. During the first 48 weeks, no patients changed their treatment due to toxicity, and 4 patients (all with baseline VL ≥ 50 copies/ml) changed due to virological failure. Conclusions: EVG/COB/TFV/FTC + DRV was well tolerated and effective in treatment-experienced patients with undetectable viral load as a simplification strategy, allowing once-daily, two-pill regimen with three antiretroviral drug classes. Effectiveness was low in patients with detectable viral loads